When was Generation Bio Co. stock made available for the first time to the public?

The IPO Date for Generation Bio Co. is 2020-06-12. On this 2020-06-12, Generation Bio Co. stock was made publicly available.

Where is the headquarters of Generation Bio Co. stock?

Headquarters of Generation Bio Co. is in US at 301 Binney Street, Cambridge, MA 02142.

What industry does Generation Bio Co. belong to?

The Generation Bio Co. belongs to Biotechnology.

Generation Bio Co.

GBIO•NASDAQ

Healthcare

Biotechnology

$4.27

$0.06(1.43%)

Generation Bio Co. (GBIO) Company Profile & Overview

Explore Generation Bio Co.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Generation Bio Co. (GBIO) Company Profile & Overview

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

SectorHealthcare

IndustryBiotechnology

CEOCameron Geoffrey McDonough

Contact Information

https://generationbio.com

617 655 7500

301 Binney Street, Cambridge, MA, 02142

Company Facts

115 Employees

IPO DateJun 12, 2020

CountryUS

Actively Trading

Frequently Asked Questions

;